| Literature DB >> 33924656 |
Sojeong Kim1, Eun-Young Lee2, Prima F Hillman2, Jaeyoung Ko3, Inho Yang4, Sang-Jip Nam2.
Abstract
Salicornia europaea L. is a halophyte that grows in salt marshes and muddy seashores, which is widely used both as traditional medicine and as an edible vegetable. This salt-tolerant plant is a source of diverse secondary metabolites with several therapeutic properties, including antioxidant, antidiabetic, cytotoxic, anti-inflammatory, and anti-obesity effects. Therefore, this review summarizes the chemical structure and biological activities of secondary metabolites isolated from Salicornia europaea L.Entities:
Keywords: Salicornia europaea L.; halophyte; phytochemicals; secondary metabolites
Mesh:
Substances:
Year: 2021 PMID: 33924656 PMCID: PMC8069253 DOI: 10.3390/molecules26082252
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Chemical structures of oleanane triterpenoid saponins isolated from Salicornia europaea (1–21).
Reported biological activities of compounds 1–21.
| No. | Biological Activities 1 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Antioxidant | Antidiabetic | Cytotoxic | Antibacterial/ | Anti-Inflammatory | Others | ||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||
|
| >>5 × 102 | 4.9 | 6.6 | O | |||||||||||
|
| 3.9 × 102 | <<1 | <<1 | ||||||||||||
|
| >>5 × 102 | 21.9 | 20.4 | Pancreatic lipase inhibitory, hepatoprotective | |||||||||||
|
| >>5 × 102 | 7.1 | 1.4 | ||||||||||||
|
| |||||||||||||||
|
| 251.7 | 47.4 | 28.2 | O | O | α-Amylase inhibitory | |||||||||
|
| 7.4 | 7.9 | 17.7 | 44.1 | 47.2 | 33.2 | O | O | |||||||
|
| 5.4 | 56.0 | 97.5 | 29.9 | Spermicidal | ||||||||||
|
| 20.7 | 13.3 | 9.6 | 25.1 | Anticlotting | ||||||||||
|
| O | O | O | O | O | Hepatoprotective, antihypertensive, antiparasitic, antiviral | |||||||||
|
| 22.5 | 9.0 | O | ||||||||||||
|
| 52.4 | ||||||||||||||
|
| 79.4 | ||||||||||||||
|
| |||||||||||||||
|
| 9 | 27.8 | 48.8 | 51.9 | O | Anti-HIV-1 protease, fibrillogenesis inhibitory | |||||||||
|
| O | ||||||||||||||
|
| |||||||||||||||
|
| O | O | |||||||||||||
|
| O | PTP1B inhibitory | |||||||||||||
|
| O | O | Antiviral, antithrombotic, insulinotropic, anti-obesity | ||||||||||||
|
| |||||||||||||||
1 Qualitative bioassay study reported without quantitative data was marked with O.
Figure 2Chemical structures of caffeoylquinic acids isolated from Salicornia europaea (22–35).
Reported biological activities of compounds 22–35.
| No. | Biological Activities 1 | ||||||
|---|---|---|---|---|---|---|---|
| Antioxidant | Antidiabetic | Cytotoxic | Antibacterial | Anti-Inflammatory | Anti-HMGB1 | Others | |
|
| |||||||
|
| 5.1 | O | O | Hepatoprotective, lipogenesis inhibitory | |||
|
| 6.1 | O | O | O | O | Neuroprotective, antithrombotic, hepatoprotective, antiviral, | |
|
| O | O | O | O | O | X | Neuroprotective, anti-melanogenic |
|
| 3.4 | O | O | O | Neuroprotective, antithrombotic, antihyperlipidemic, antiviral | ||
|
| O | ||||||
|
| O | O | |||||
|
| X | ||||||
|
| 9.2 | O | O | ||||
|
| O | ||||||
|
| O | Influenza A neuraminidase inhibitory, neuroprotective | |||||
|
| O | ||||||
|
| O | ||||||
|
| O | ||||||
|
| O | ||||||
1 Qualitative bioassay study reported without quantitative data was marked with O.
Figure 3Chemical structures of flavonoids isolated from Salicornia europaea (36–51).
Reported biological activities of compounds 36–51.
| No. | Biological Activities 1 | |||||
|---|---|---|---|---|---|---|
| Antioxidant | Antidiabetic | Cytotoxic | Anti-Inflammatory | Anti-HMGB1 | Others | |
|
| ||||||
|
| ||||||
|
| ||||||
|
| ||||||
|
| O | 65.4 | ||||
|
| O | 105.9 | O | O | Cardiovascular protection | |
|
| O | 64.6 | O | O | Cardiovascular protection | |
|
| O | O | O | O | Cardiovascular protection | |
|
| O | O | O | anti-obesity | ||
|
| O | |||||
|
| O | |||||
|
| O | |||||
|
| O | Antiglycation | ||||
|
| O | O | O | Antiapoptotic, cardioprotective | ||
|
| O | 73.4 | O | O | Neuroprotective, cardioprotective | |
|
| O | 227.5 | O | O | Neuroprotective, cardioprotective | |
|
| O | O | Antifungal, estrogenic | |||
1 Qualitative bioassay study reported without quantitative data was marked with O.
Figure 4Chemical structures of chromones isolated from Salicornia europaea (52–57).
Reported biological activities of compounds 52–57.
| No. | Biological Activity 1 |
|---|---|
|
| |
|
| |
|
| O |
|
| |
|
| |
|
| O |
|
| O |
1 Qualitative bioassay study reported without quantitative data was marked with O.
Figure 5Chemical structures of sterols isolated from Salicornia europaea (58–62).
Reported biological activities of compounds 58–62.
| No. | Biological Activities 1 | |||||
|---|---|---|---|---|---|---|
| Antioxidant | Antidiabetic | Cytotoxic | Anti-Inflammatory | Anticancer | Others | |
|
| ||||||
|
| O | O | O | O | Hypocholesterolemic, immunodulatory, neuroprotective | |
|
| O | O | O | Anti-osteoarthritic, anti-hypercholesterolemic, antitumor, hypolgycemic, antimuatiogenic | ||
|
| O | O | Immunoregulatory, proliferation of neural stem cell | |||
|
| Antimicrobial, antibiotic | |||||
1 Qualitative bioassay study reported without quantitative data was marked with O.
Figure 6Chemical structures of sterols isolated from Salicornia europaea (63–68).
Reported biological activities of compounds 63–68.
| No. | Biological Activities 1 | ||
|---|---|---|---|
| Antioxidant | Anti-Inflammatory | Others | |
|
| |||
|
| 10.5 | O | Antiestrogenic, antitumor |
|
| O | ||
|
| O | ||
|
| 19.5 | O | Antiplatelet, nitric oxide inhibition, P-glycoprotein inhibition |
|
| O | NQO1-inducing | |
|
| O | O | Anticholinergic, anti-neuroinflammatory, anti-amnesic |
1 Qualitative bioassay study reported without quantitative data was marked with O.
Figure 7Chemical structures of aliphatic compounds isolated from Salicornia europaea (69–75).
Reported biological activities of compounds 69–74.
| No. | Biological Activities 1 | |||
|---|---|---|---|---|
| Antioxidant | Cytotoxic | Others | ||
|
|
| |||
|
| O | O | Antiproliferative | |
|
| O | O | Antiproliferative | |
|
| O | O | Antiproliferative | |
|
| O | 65.4 | 83.2 | Antiproliferative |
|
| ||||
|
| ||||
|
| Antiaggregatory, cytoprotective, antiparkinsonian | |||
1 Qualitative bioassay study reported without quantitative data was marked with O.
Figure 8Chemical structures of isolates from Salicornia europaea (76–89).
Reported biological activities of compounds 76–89.
| No. | Biological Activities 1 | |||||||
|---|---|---|---|---|---|---|---|---|
| Antioxidant | Antidiabetic | Cytotoxic | Anti-Inflammatory | Antibacterial | Others | |||
|
|
|
|
|
| ||||
|
| O | O | O | O | O | Anticancer, anti-ulcerantiaging, antifibrotic, antiviral | ||
|
| O | O | O | Anti-microbial, anticancer | ||||
|
| O | O | O | O | O | Antiviral, anti-atherosclerotic, immunostimulatory, cardioprotective, antiproliferative, hepatoprotective, anticancer, antihepatocarcinoma | ||
|
| ||||||||
|
| O | |||||||
|
| O | 78.5 | O | Antimicrobial, apoptosis- and autophagy-modulating, anxiolytic, anticonvulsant, immunomodulatory, antinociceptive | ||||
|
| 27.6 | 38.6 | 56.3 | 48.9 | ||||
|
| O | O | O | Melanogenesis-inhibitory | ||||
|
| Antimicrobial, α-glucosidase inhibition, cathepsin B inhibition | |||||||
|
| O | Antidepressant | ||||||
|
| O | O | Hepatoprotective, acetylcholinesterase, hypouricemic, antifungal, immunomoudlatory, antithyroid, anti-P-388 murine leukemia cell, hypoglycemic, hypolipidemic, antiaging | |||||
|
| 17.6 | 6.2 | ||||||
|
| O | Anti-plasmodial | ||||||
|
| O | |||||||
1 Qualitative bioassay study reported without quantitative data was marked with O.
Yield of the compounds.
| Compound No. | Yield 2 (ppm) | Note 1 and | Compound No. | YieldN 2 (ppm) | Note 1 and | Compound No. | Yield 2 (ppm) | Note 1 and |
|---|---|---|---|---|---|---|---|---|
|
| 123.9 | Dried [ |
| 0.2 | Wet |
| 0.2 | Wet [ |
|
| N.A. |
| 0.3 |
| 0.12 | |||
|
| N.A. |
| 1.3 |
| 0.2 | Wet [ | ||
|
| N.A. |
| 0.2 |
| 0.2 | |||
|
| 0.1 | Wet |
| 0.4 |
| 0.3 | ||
|
| 0.2 |
| 1.6 | Wet |
| N.A. | ||
|
| 0.1 |
| 0.9 |
| 0.2 | Wet [ | ||
|
| 0.1 |
| 0.4 |
| 3.8 | Wet [ | ||
|
| 0.1 |
| 700 | Dried |
| 0.3 | Wet [ | |
|
| 0.6 | Wet |
| 93.3 |
| 0.5 | ||
|
| 0.5 |
| 466.7 |
| 0.6 | |||
|
| 0.3 |
| 33.3 |
| 0.2 | |||
|
| 0.4 |
| 41.7 |
| 0.1 | Wet [ | ||
|
| 0.1 | Wet |
| 0.5 | Wet [ |
| 0.1 | |
|
| 0.1 |
| 0.9 | Dried [ |
| 0.1 | ||
|
| 0.1 |
| 0.6 |
| 1.54 | Dried [ | ||
|
| 0.1 |
| 0.7 |
| 8.54 | |||
|
| 0.1 |
| 0.1 | Wet [ |
| 6.87 | ||
|
| 0.2 |
| 0.3 |
| 1.3 | Dried [ | ||
|
| 0.1 |
| 0.1 |
| 0.9 | Wet [ | ||
|
| 0.1 |
| N.A. |
| 0.2 | Wet [ | ||
|
| 8 | Dried [ |
| 0.3 | Wet [ |
| 1.2 | |
|
| 6.2 | Wet |
| 0.4 |
| 0.3 | ||
|
| 0.1 |
| 0.5 |
| 0.2 | |||
|
| 0.4 |
| 0.3 |
| 0.5 | |||
|
| 0.6 |
| 0.4 | Dried [ |
| 0.2 | ||
|
| 16.3 | Dried |
| 0.4 |
| 1.1 | Wet [ | |
|
| 1.4 |
| 20.7 | Dried [ |
| 0.6 | ||
|
| 12.8 |
| 9.7 |
| 0.9 | |||
|
| 1.7 |
| 0.3 | Wet [ |
1 Plant material status before extraction. Dried or Wet. 2 data Not Available (N.A.).